Azelastine Hydrochloride
Product Description
Deva Holding A.S.
-
TR -
2015On CPHI since
-
3Certificates
-
1000 - 4999Employees
Company types
Categories
Deva Holding A.S.
-
TR
-
2015On CPHI since
-
3Certificates
-
1000 - 4999Employees
Company types
More Products from Deva Holding A.S. (99)
-
Product Ampicillin sodium + Sulbactam Sodium
250+125, 500+250, 1000+500 mg (IM) Injectable (vial) -
Product Anastrozole
1mg Tablets -
Product Apremilast*
10mg, 20mg, 30mg Tablets -
Product Atorvastatin Calcium Trihydrate
10, 20, 40, 80 mg Film Coated Tablet -
Product Azacitidine
100 mg SC Injectable (Powder for Injection) -
Product Azelastine Hydrochloride
0.05 % Ophthalmic Eye Drops (single-dose) -
Product Azithromycin Dihydrate
250, 500 mg Film Coated Tablet -
Product Beclomethasone dipropionate
100 µg (200 dose) Nasal Spray -
Product Bendamustine Hydrochloride
25, 100 mg (IV) Injectable (vial containing lyophilised powder for infusion) -
Product Benidipine HCl
4, 8 mg Film Coated Tablet -
Product Bicalutamide
50, 150 mg Film Coated Tablet -
Product Bimatoprost
0.01% Ophthalmic Eye Drops
Deva Holding A.S. resources (1)
-
Brochure Deva EU Markets Product List
Deva EU Markets Product List
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance